Research Benefits:
- Combo of cagrilintide (amylin analog) + GLP‑1S (GLP‑1R agonist) for multi‑target assays
- Supports in vitro profiling of amylin and GLP‑1 receptor signaling pathways
- Useful for exploring energy‑balance/appetite signaling interactions in cell models
- Enables evaluation of secretion and metabolic biomarker readouts in vitro
Blend Specification:
- Cagrilintide 5mg
- GLP-1S 5mg
Description
Cagrilintide 5mg + GLP-1S 5mg is a novel combination research peptide, gaining attention for its potential applications in metabolic studies, weight management, and diabetes-related research. This synergistic formulation combines the GLP-1 receptor agonist effects of Semaglutide with the amylin analog properties of Cagrilintide, offering a dual mechanism of action to explore innovative therapeutic avenues.
Key Features:
- High Purity and Quality: Synthesized from premium raw materials and produced under rigorous industry standards to ensure exceptional purity and research consistency.
- Comprehensive Testing: Each batch undergoes strict quality assurance processes, including advanced analytical techniques to confirm integrity and efficacy.
- Lyophilized Format: Delivered in a freeze-dried state to ensure optimal stability and performance when stored under recommended conditions.
Applications:
- Investigating potential combined effects on weight management and appetite regulation.
- Exploring synergistic impacts on glucose metabolism and insulin sensitivity.
- Examining therapeutic implications for type 2 diabetes and related metabolic disorders.
- Studying broader applications in metabolic disease management and treatment strategies.
Specifications and Documentation:
- Material Safety Data Sheet (MSDS): Coming Soon.
- Handling and Storage Instructions: Coming Soon.
Cagrilintide 5mg + GLP-1S 5mg represents an exciting development in research peptides, offering researchers a powerful tool for advancing understanding in the field of metabolic and diabetes-focused studies.
Additional information
| CAS No. | 910463-68-2 |
|---|---|
| Purity | ≥99% |
| Sequence | His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| Molecular Formula | C187H291N45O59 |
| Molecular Weight | 4113.64 g/mol |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Metabolic function research, obesity management, type 2 diabetes studies |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |




Reviews
There are no reviews yet.